Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity
Ryota Tanaka(University of Tsukuba), Manabu Fujimoto(Osaka Gakuin University), Mari Okune(University of Tsukuba), Yasuhiro Fujisawa(University of Tsukuba), Naoko Okiyama(Tokyo Medical and Dental University), Junichi Furuta(University of Tsukuba), Rei Watanabe(Osaka Ohtani University), Yosuke Ishitsuka(University of Colorado Anschutz Medical Campus), Hiroshi Maruyama(Panasonic (Japan)), Mikio Ohtsuka(University of Tsukuba), Atsushi Otsuka(Kyoto University)
Cited by 132
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438